Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESTHER-1: Follitropin Delta vs Follitropin Alfa in IVF
NCT01956110Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Oct 2013
- Primary completion
- May 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 11
01
Overview
Phase 3, randomised, single-blind trial of follitropin delta in infertility (2 arms), sponsored by Ferring Pharmaceuticals. Primary endpoints: Ongoing Pregnancy Rate and Ongoing Implantation Rate. Started Oct 2013; status: completed.
02
Drugs
follitropin delta
03
Conditions
infertility
Beyond the preview
Go deeper on NCT01956110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01956110.